Fate Therapeutics Financial Statements 2011-2023 | FATE
Format: Annual
Loading...
Annual Data | Millions of US $ except per share data
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
2018-12-31
2017-12-31
2016-12-31
2015-12-31
2014-12-31
Cost Of Goods Sold
-
-
-
-
-
-
-
-
-
-
$172.596
$320.454
$215.519
$125.623
$87.77
$56.024
$34.358
$26.452
$19.861
$16.435
Other Operating Income Or Expenses
-
-
-
-
-
-
-
-
-
-
Operating Expenses
-
-
-
-
-
-
-
-
-
-
$-190.511
$-308.386
$-216.994
$-128.085
$-100.727
$-67.092
$-42.125
$-31.963
$-27.782
$-24.904
$29.583
$26.665
$4.843
$-45.302
$2.578
$0.494
$-0.827
$-1.499
$-2.21
$-0.979
Income Taxes
-
-
-
-
-
-
-
-
-
-
$-160.928
$-281.721
$-212.151
$-173.387
$-98.149
$-66.598
$-42.952
$-33.462
$-29.992
$-25.883
Other Income
-
-
-
-
-
-
-
-
-
-
$-160.928
$-281.721
$-212.151
$-173.387
$-98.149
$-66.598
$-42.952
$-33.462
$-29.992
$-25.883
Income From Discontinued Operations
-
-
-
-
-
-
-
-
-
-